Gyre Therapeutics, Inc.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2011 | $-22.0M | $-22.6M | $598.0K | $2.2M |
| Jun 2011 | $-23.1M | $-23.5M | $414.0K | $2.2M |
| Sep 2011 | $-18.1M | $-18.2M | $167.0K | $2.1M |
| Dec 2011 | $-20.5M | $-20.8M | $252.0K | $2.0M |
| Mar 2012 | $-24.9M | $-24.9M | $46.0K | $1.9M |
| Jun 2012 | $-17.3M | $-17.4M | $91.0K | $3.1M |
| Sep 2012 | $-10.4M | $-10.4M | $1.0K | $1.4M |
| Dec 2012 | $-11.6M | $-11.8M | $195.0K | $1.4M |
| Mar 2013 | $-9.3M | $-9.4M | $70.0K | $1.6M |
| Jun 2013 | $-10.4M | $-10.4M | $22.0K | $1.3M |
| Sep 2013 | $-9.7M | $-9.7M | $0 | $1.3M |
| Dec 2013 | $-11.2M | $-11.1M | $-51.0K | $-3.9M |
| Mar 2014 | $-14.8M | $-14.8M | — | $825.0K |
| Jun 2014 | $-8.9M | $-8.9M | — | $985.0K |
| Sep 2014 | $19.4M | $19.4M | — | $-1.6M |
| Dec 2014 | $-2.1M | $-2.1M | — | $55.0K |
| Mar 2015 | $-3.0M | $-3.0M | — | $44.0K |
| Jun 2015 | $-1.4M | $-1.4M | — | $39.0K |
| Sep 2015 | $-9.6M | $-9.6M | — | $52.0K |
| Dec 2015 | $-5.1M | $-5.1M | — | $191.0K |
| Mar 2016 | $-4.7M | $-4.8M | $89.0K | $153.0K |
| Jun 2016 | $-3.6M | $-3.9M | $235.0K | $165.0K |
| Sep 2016 | $-5.1M | $-5.1M | $22.0K | $187.0K |
| Dec 2016 | $-5.0M | $-5.1M | $122.0K | $130.0K |
| Mar 2017 | $-4.3M | $-4.3M | $3.0K | $120.0K |
| Jun 2017 | $-4.4M | $-4.4M | $0 | $111.0K |
| Sep 2017 | $-4.9M | $-4.9M | $0 | $325.0K |
| Dec 2017 | $-6.3M | $-6.3M | $20.0K | $307.0K |
| Mar 2018 | $-5.1M | $-5.3M | $198.0K | $606.0K |
| Jun 2018 | $-7.4M | $-7.4M | $3.0K | $550.0K |
| Sep 2018 | $-7.0M | $-7.0M | $0 | $710.0K |
| Dec 2018 | $-9.0M | $-9.2M | $175.0K | $740.0K |
| Mar 2019 | $-15.0M | $-15.0M | $15.0K | $829.0K |
| Jun 2019 | $-11.5M | $-11.5M | $49.0K | $903.0K |
| Sep 2019 | $-9.1M | $-9.1M | $1.0K | $801.0K |
| Dec 2019 | $-8.1M | $-8.1M | $-1.0K | $671.0K |
| Mar 2020 | $-4.8M | $-4.8M | $17.0K | $805.0K |
| Jun 2020 | $-15.1M | $-15.2M | $16.0K | $834.0K |
| Sep 2020 | $-13.0M | $-13.2M | $195.0K | $1.1M |
| Dec 2020 | $-22.1M | $-22.1M | — | $920.0K |
| Mar 2021 | $-24.4M | $-24.4M | — | $1.0M |
| Jun 2021 | $-20.1M | $-20.1M | — | $983.0K |
| Sep 2021 | $-21.6M | $-21.6M | — | $713.0K |
| Dec 2021 | $-17.7M | $-17.7M | — | $683.0K |
| Mar 2022 | $-12.1M | $-12.1M | — | $515.0K |
| Jun 2022 | $-12.3M | $-12.3M | — | $346.0K |
| Sep 2022 | $-7.3M | $-7.3M | — | $224.0K |
| Dec 2022 | $42.3M | $42.3M | — | $12.3M |
| Mar 2023 | $10.4M | $8.7M | $1.7M | $210.0K |
| Jun 2023 | $4.5M | $2.1M | $2.5M | $89.0K |
| Sep 2023 | $7.6M | $5.6M | $2.0M | $98.0K |
| Dec 2023 | $3.4M | $1.0M | $2.3M | $6.9M |
| Mar 2024 | $2.9M | $2.7M | $231.0K | $11.0K |
| Jun 2024 | $-5.5M | $-6.9M | $1.5M | $16.0K |
| Sep 2024 | $1.7M | $1.0M | $693.0K | $237.0K |
| Dec 2024 | $-2.8M | $-2.7M | $-65.0K | $567.0K |
| Mar 2025 | $-129.0K | $-251.0K | $122.0K | $507.0K |
| Jun 2025 | $-7.5M | $-7.8M | $335.0K | $1.4M |
| Sep 2025 | $14.2M | $13.6M | $589.0K | $617.0K |
| Dec 2025 | $-5.6M | $-5.8M | $144.0K | $4.6M |
| Mar 2026 | $3.2M | $3.0M | $178.0K | $2.6M |
| Jun 2026 | $-16.7M | $-17.0M | $262.0K | $2.1M |